Report on Business Magazine Top 1000 - Company Snapshot

CANGENE CORPORATION

CANGENE CORPORATION is a biopharmaceutical company that develops, manufactures and markets therapeutic products, particularly specialty plasma products (hyperimmunes) aimed at biodefence and infectious disease targets. Its Cangene bioPharma,Inc. subsidiary in Baltimore, houses its contract R&D & manufacturing & U.S.commercial operations. It collects its own plasma through Cangene Plasma Resources.

Address: 55 Innovation Drive , Winnipeg, MB, R3T 5Y3
Phone: 204 - 275-4200
Fax: 204 - 269-7003
Web Site:www.cangene.com
E-Mail:ir@cangene.com
CEO: John Sedor, President & C.E.O.
CFO: Michael Graham, C.F.O.
HR : N/A

LATEST ANNUAL FINANCIALS
Date of Balance Sheet: 31-Jul-2013
12 Months, US$
Total Revenue ($000): 132,033
% Change Revenue: 15.8
Profit/Loss ($000): 1,358
Employees: 472

GENERAL INFORMATION
Stock Symbol:
Exchanges:
Industry: BIOTECHNOLOGY & PHARMACEUTICAL
Company Type: DEFUNCT
Company Status: DEFUNCT


For more information on this company or any other North America publicly traded stock try globeinvestor.com.

© Copyright 2007 CTVglobemedia Publishing Inc. All Rights Reserved.
Last Updated 25-Sep-2014